Abstract
Approximately 75–90% of people with type 2 diabetes (T2D) are treated with glucose-lowering drugs (GLDs) and Low drug adherence has been a persisting challenge in diabetes management. we aimed to identify factors associated with adherence to GLDs and investigate if these factors vary by class.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
